Literature DB >> 15679106

Biological roles of APP in the epidermis.

Volker Herzog1, Gregor Kirfel, Christina Siemes, Anton Schmitz.   

Abstract

The amyloid precursor protein (APP) was initially detected in cells of the central nervous system where it is considered to be involved in the pathogenesis of Alzheimer's disease. However, APP is also found in peripheral organs with exceptionally strong expression in the mammalian epidermis where it fulfils a variety of distinct biological roles. Full length APP appears to facilitate keratinocyte adhesion due to its ability to interact with the extracellular matrix. The C-terminus of APP also serves as adapter protein for binding the motor protein kinesin thereby mediating the centripetal transport of melanosomes in epidermal melanocytes. By the action of alpha-secretase sAPPalpha, the soluble N-terminal portion of APP, is released. sAPPalpha has been shown to be a potent epidermal growth factor thus stimulating proliferation and migration of keratinocytes as well as the exocytic release of melanin by melanocytes. The release of sAPPalpha can be almost completely blocked by inhibiting alpha-secretase with hydroxamic acid-based zinc metalloproteinase inhibitors. In hyperproliferative keratinocytes from psoriatic skin this inhibition results in normalized growth.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15679106     DOI: 10.1078/0171-9335-00401

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  13 in total

Review 1.  An overview of APP processing enzymes and products.

Authors:  Vivian W Chow; Mark P Mattson; Philip C Wong; Marc Gleichmann
Journal:  Neuromolecular Med       Date:  2010-03       Impact factor: 3.843

Review 2.  Role of APP Interactions with Heterotrimeric G Proteins: Physiological Functions and Pathological Consequences.

Authors:  Philip F Copenhaver; Donat Kögel
Journal:  Front Mol Neurosci       Date:  2017-01-31       Impact factor: 5.639

3.  Neurofibromin and amyloid precursor protein expression in dopamine D3 receptor knock-out mice brains.

Authors:  Alessandro Castorina; Gian Marco Leggio; Salvatore Giunta; Gaetano Magro; Giovanni Scapagnini; Filippo Drago; Velia D'Agata
Journal:  Neurochem Res       Date:  2010-12-19       Impact factor: 3.996

4.  Salivary Aβ Secretion and Altered Oral Microbiome in Mouse Models of AD.

Authors:  Angela M Floden; Mona Sohrabi; Suba Nookala; Jay J Cao; Colin K Combs
Journal:  Curr Alzheimer Res       Date:  2020       Impact factor: 3.498

5.  Measurement of altered AβPP isoform expression in frontal cortex of patients with Alzheimer's disease by absolute quantification real-time PCR.

Authors:  William G Tharp; Yong-Ho Lee; Shane M Greene; Elise Vincellete; Thomas G Beach; Richard E Pratley
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

6.  Skin Mirrors Brain: A Chance for Alzheimer's Disease Research.

Authors:  Christos C Zouboulis; Evgenia Makrantonaki; Amir M Hossini
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Expression and function of APP and its metabolites outside the central nervous system.

Authors:  Kendra L Puig; Colin K Combs
Journal:  Exp Gerontol       Date:  2012-07-27       Impact factor: 4.032

8.  APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease.

Authors:  Gunjan D Manocha; Angela M Floden; Keiko Rausch; Joshua A Kulas; Brett A McGregor; Lalida Rojanathammanee; Kelley R Puig; Kendra L Puig; Sanjib Karki; Michael R Nichols; Diane C Darland; James E Porter; Colin K Combs
Journal:  J Neurosci       Date:  2016-08-10       Impact factor: 6.167

9.  Disseminate Recurrent Folliculitis and Hidradenitis Suppurativa Are Associated Conditions: Results From a Retrospective Study of 131 Patients With Down Syndrome and a Cohort of 12,351 Pediatric Controls.

Authors:  Andrea Sechi; Alba Guglielmo; Annalisa Patrizi; Francesco Savoia; Guido Cocchi; Miriam Leuzzi; Marco A Chessa
Journal:  Dermatol Pract Concept       Date:  2019-07-31

10.  Cellular and animal models for high-throughput screening of therapeutic agents for the treatment of the diseases of the elderly in general and Alzheimer's disease in particular(†).

Authors:  Jordan L Holtzman
Journal:  Front Pharmacol       Date:  2013-05-13       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.